Name | N,N-dimethyl-2-(4-methylpiperazin-1-yl)ethanamine |
---|---|
Synonyms |
Piperazine, 1-[2- (dimethylamino)ethyl]-4-methyl-
Kaolizer 8 N-Methyl-N'-(β-dimethylaminoethyl)piperazine 1-Piperazineethanamine,N,N,4-trimethyl N,N,4-trimethyl-1-piperazineethanamine EINECS 203-183-7 1-(2-DIMETHYLAMINOETHYL)-4-METHYLPIPERAZINE 1-[2-(Dimethylamino)ethyl]-4-methylpiperazine N,N-Dimethyl-2-(4-methylpiperazin-1-yl)ethanamine MFCD00059773 N,N-Dimethyl-2-(4-methyl-1-piperazinyl)ethanamine 1-Piperazineethanamine, N,N,4-trimethyl- Toyocat NP |
Density | 0.9±0.1 g/cm3 |
---|---|
Boiling Point | 207.5±8.0 °C at 760 mmHg |
Molecular Formula | C9H21N3 |
Molecular Weight | 171.283 |
Flash Point | 74.5±9.0 °C |
Exact Mass | 171.173553 |
PSA | 9.72000 |
LogP | -0.45 |
Vapour Pressure | 0.2±0.4 mmHg at 25°C |
Index of Refraction | 1.476 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Risk Phrases | R36/37/38 |
---|---|
Safety Phrases | S26-S36/37/39 |
RIDADR | 2922 |
RTECS | TL6125000 |
Packaging Group | II |
Hazard Class | 8 |
HS Code | 2933599090 |
~% 104-19-8
Detail
|
Literature: Journal of the American Chemical Society, , vol. 107, # 2 p. 361 - 369 |
~% 104-19-8
Detail
|
Literature: Journal of the American Chemical Society, , vol. 107, # 2 p. 361 - 369 |
~% 104-19-8 |
Literature: GB901197 , ; |
~% 104-19-8 |
Literature: Monatshefte fuer Chemie, , vol. 82, p. 880,897 Journal of the Chemical Society, , p. 1881,1893 |
~% 104-19-8 |
Literature: Ann.Rep.Tanabe pharm.Res.Chem.Abstr., , vol. 1, # 1 p. 7 Ann.Rep.Tanabe pharm.Res.Chem.Abstr., , p. 6651 |
~% 104-19-8 |
Literature: Journal of Organic Chemistry, , vol. 13, p. 134,138 |
~% 104-19-8 |
Literature: Monatshefte fuer Chemie, , vol. 82, p. 880,897 |
~% 104-19-8 |
Literature: Monatshefte fuer Chemie, , vol. 82, p. 880,897 Journal of the Chemical Society, , p. 1881,1893 |
~%
Detail
|
Literature: Monatshefte fuer Chemie, , vol. 82, p. 880,897 |
Precursor 10 | |
---|---|
DownStream 0 |
HS Code | 2933599090 |
---|---|
Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |